AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32009828 — intervention group
Group type: COMPARATOR
Intervention: Tailor‐made standard rehabilitation (TMSR)
Number of subjects: 262
Study 36151557 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin initiated based on HbA1c ≥ 7.5% (n=2809)
Number of subjects: 3713
Study 36151557 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin initiated based on clinical characteristics
Number of subjects: 3713
Study 36151557 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin initiated based on combined clinical characteristics and novel biomarkers
Number of subjects: 3713
Study 36151557 — intervention group
Group type: COMPARATOR
Intervention: Canagliflozin initiated based on HbA1c or UACR alone
Number of subjects: 3713
Study 34020263 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic fermented dairy food (N = 79)
Number of subjects: 262
Study 34020263 — intervention group
Group type: COMPARATOR
Intervention: Placebo fermented dairy food (N = 85)
Number of subjects: 262
Study 34020263 — intervention group
Group type: COMPARATOR
Intervention: Diet-as-usual (N = 98)
Number of subjects: 262
Study 35275529 — intervention group
Group type: EXPERIMENTAL
Intervention: DHP1401 500 mg
Number of subjects: 180
Study 35275529 — intervention group
Group type: EXPERIMENTAL
Intervention: DHP1401 1000 mg
Number of subjects: 180
Study 35275529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 180
Study 35275529 — intervention group
Group type: EXPERIMENTAL
Intervention: DHP1401 500 mg and Donepezil 5 mg
Number of subjects: 180
Study 32691198 — intervention group
Group type: EXPERIMENTAL
Intervention: Casino players
Number of subjects: 10000
Study 32691198 — intervention group
Group type: EXPERIMENTAL
Intervention: Sports bettors
Number of subjects: 10000
Study 35457349 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized education on breast cancer using a mobile medical app based on algorithms with conditions
Number of subjects: 500
Study 35457349 — intervention group
Group type: COMPARATOR
Intervention: Control group (no personalized education)
Number of subjects: 500
Study 33211076 — intervention group
Group type: EXPERIMENTAL
Intervention: SB11
Number of subjects: 705
Study 33211076 — intervention group
Group type: COMPARATOR
Intervention: Ranibizumab
Number of subjects: 705
Study 33556589 — intervention group
Group type: EXPERIMENTAL
Intervention: web-based stepped collaborative care intervention
Number of subjects: 450
Study 33556589 — intervention group
Group type: COMPARATOR
Intervention: screening and referral arm
Number of subjects: 450
Study 32164728 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternity waiting homes (MWHs) intervention
Number of subjects: 0
Study 32164728 — intervention group
Group type: EXPERIMENTAL
Intervention: Implementation effectiveness of MWH model
Number of subjects: 0
Study 32164728 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine health facility assessment
Number of subjects: 0
Study 35449384 — intervention group
Group type: EXPERIMENTAL
Intervention: Pain provocation after the first 10 minutes of upright position
Number of subjects: 101
Study 35449384 — intervention group
Group type: COMPARATOR
Intervention: Standard tilt table test with no provocation for further 30 minutes
Number of subjects: 101
Study 33389796 — intervention group
Group type: EXPERIMENTAL
Intervention: Intralesional combined digoxin and furosemide
Number of subjects: 40
Study 33389796 — intervention group
Group type: COMPARATOR
Intervention: Intralesional normal saline
Number of subjects: 40
Study 32496286 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational handover describing weaknesses in communication
Number of subjects: 72
Study 32496286 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational handover describing weaknesses in medical expertise
Number of subjects: 72
Study 32496286 — intervention group
Group type: COMPARATOR
Intervention: No educational handover (control)
Number of subjects: 72
Study 34772740 — intervention group
Group type: COMPARATOR
Intervention: Older adults
Number of subjects: 72
Study 34772740 — intervention group
Group type: EXPERIMENTAL
Intervention: Young adults
Number of subjects: 72
Study 33567928 — intervention group
Group type: COMPARATOR
Intervention: Antiviral drug (oseltamivir) alone
Number of subjects: 284
Study 33452871 — intervention group
Group type: EXPERIMENTAL
Intervention: Canakinumab treatment
Number of subjects: 0
Study 33452871 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 0
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with EOC
Number of subjects: 379
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with high FIGO stage (III+IV)
Number of subjects: 379
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with lymph node metastasis
Number of subjects: 379
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels in patients with chemoresistance
Number of subjects: 379
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum miR‐125b levels preoperative vs postoperative
Number of subjects: 379
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum miR‐125b in combination with serum CA125
Number of subjects: 379
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Low levels of miR‐125b
Number of subjects: 379
Study 32107956 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensitivity and specificity of serum miR‐125b
Number of subjects: 379
Study 36253766 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-delivered behavioral activation (Tele-BA)
Number of subjects: 277
Study 36253766 — intervention group
Group type: EXPERIMENTAL
Intervention: Tele-delivered problem-solving therapy (Tele-PST)
Number of subjects: 277
Study 36253766 — intervention group
Group type: COMPARATOR
Intervention: Tele-BA
Number of subjects: 277
Study 36253766 — intervention group
Group type: COMPARATOR
Intervention: Attention control (AC)
Number of subjects: 277
Study 34034766 — intervention group
Group type: EXPERIMENTAL
Intervention: Convolutional neural network model for automated laryngeal mass detection
Number of subjects: 0
Study 34034766 — intervention group
Group type: EXPERIMENTAL
Intervention: Original computer algorithm
Number of subjects: 0
Study 34034766 — intervention group
Group type: EXPERIMENTAL
Intervention: Embedded pilot system for home-based self-screening test
Number of subjects: 0
Study 32807013 — intervention group
Group type: EXPERIMENTAL
Intervention: 1-Hz rTMS over contralesional M1, 30-minute sessions, 2 weeks duration
Number of subjects: 77
Study 32807013 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS, 30-minute sessions, 2 weeks duration
Number of subjects: 77
Study 35083965 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedle fractional radiofrequency (MFR)
Number of subjects: 15
Study 35083965 — intervention group
Group type: COMPARATOR
Intervention: Non-ablative 1565 nm fractional laser (NAFL)
Number of subjects: 15
Study 35083965 — intervention group
Group type: COMPARATOR
Intervention: NAFL
Number of subjects: 15
Study 35083965 — intervention group
Group type: EXPERIMENTAL
Intervention: MFR
Number of subjects: 15
Study 33449527 — intervention group
Group type: EXPERIMENTAL
Intervention: Cellex (0.1 mg daily SC for 10 days)
Number of subjects: 40
Study 33449527 — intervention group
Group type: COMPARATOR
Intervention: Cortexin (10 mg per 2 ml of 0.9% NaCl solution IM daily for 10 days)
Number of subjects: 40
Study 33587381 — intervention group
Group type: EXPERIMENTAL
Intervention: DaxibotulinumtoxinA for Injection (DAXI)
Number of subjects: 2989
Study 33587381 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2989
Study 32654902 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC‐TT (n = 141)
Number of subjects: 284
Study 32654902 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC‐CRM (n = 143)
Number of subjects: 284
Study 32654902 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC‐TT
Number of subjects: 284
Study 32654902 — intervention group
Group type: EXPERIMENTAL
Intervention: MCC‐CRM
Number of subjects: 284
Study 32654902 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 284
Study 36328306 — intervention group
Group type: EXPERIMENTAL
Intervention: Linked-color imaging (LCI)
Number of subjects: 3050
Study 36328306 — intervention group
Group type: COMPARATOR
Intervention: White-light imaging (WLI)
Number of subjects: 3050
Study 33880566 — intervention group
Group type: EXPERIMENTAL
Intervention: MNPs with IYCF counseling
Number of subjects: 4000
Study 33880566 — intervention group
Group type: COMPARATOR
Intervention: IYCF counseling only
Number of subjects: 4000
Study 32000572 — intervention group
Group type: EXPERIMENTAL
Intervention: Very low-carbohydrate high-fat (VLCHF) diet for four weeks
Number of subjects: 18
Study 32000572 — intervention group
Group type: COMPARATOR
Intervention: Normal habitual diet (HD)
Number of subjects: 18
Study 36055183 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheeled Knee Walker (WKW)
Number of subjects: 0
Study 36055183 — intervention group
Group type: COMPARATOR
Intervention: Crutches
Number of subjects: 0
Study 36055183 — intervention group
Group type: COMPARATOR
Intervention: Walker
Number of subjects: 0
Study 34591002 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative education on opioid use
Number of subjects: 95
Study 34591002 — intervention group
Group type: EXPERIMENTAL
Intervention: Depression
Number of subjects: 95
Study 34591002 — intervention group
Group type: EXPERIMENTAL
Intervention: History of prior surgical procedure
Number of subjects: 95
Study 32799791 — intervention group
Group type: EXPERIMENTAL
Intervention: C-MAC D-Blade videolaryngoscope
Number of subjects: 20
Study 32799791 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 20
Study 35860885 — intervention group
Group type: EXPERIMENTAL
Intervention: Milk chocolate
Number of subjects: 20
Study 35860885 — intervention group
Group type: EXPERIMENTAL
Intervention: Dark chocolate
Number of subjects: 20
Study 34631613 — intervention group
Group type: EXPERIMENTAL
Intervention: Acaricidal bait intervention for 8 weeks
Number of subjects: 66
Study 34631613 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention for 8 weeks
Number of subjects: 66
Study 35920515 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral program
Number of subjects: 41
Study 35920515 — intervention group
Group type: COMPARATOR
Intervention: Routine guidance from the service
Number of subjects: 41
Study 33029812 — intervention group
Group type: EXPERIMENTAL
Intervention: PDS with calcium concentration of 1.75 mmol/L (high concentration group)
Number of subjects: 102
Study 33029812 — intervention group
Group type: COMPARATOR
Intervention: PDS with calcium concentration of 1.25 mmol/L (low concentration group)
Number of subjects: 102
Study 33029812 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (low and high calcium)
Number of subjects: 102
Study 33296583 — intervention group
Group type: EXPERIMENTAL
Intervention: PSS-10
Number of subjects: 535
Study 33296583 — intervention group
Group type: EXPERIMENTAL
Intervention: PSS-4
Number of subjects: 535
Study 35131596 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole
Number of subjects: 128
Study 35131596 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride
Number of subjects: 128
Study 35131596 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 128
Study 35131596 — intervention group
Group type: COMPARATOR
Intervention: Antipsychotic-naïve patients
Number of subjects: 128
Study 32757870 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriparatide (TPTD) for 24 months
Number of subjects: 11
Study 32757870 — intervention group
Group type: COMPARATOR
Intervention: Teriparatide (TPTD) for 12 months
Number of subjects: 11
Study 36069202 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulopenem
Number of subjects: 0
Study 36069202 — intervention group
Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 0
Study 33735217 — intervention group
Group type: EXPERIMENTAL
Intervention: Lobectomy
Number of subjects: 14029
Study 33735217 — intervention group
Group type: EXPERIMENTAL
Intervention: Limited resection
Number of subjects: 14029
Study 33735217 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT)
Number of subjects: 14029
Study 33735217 — intervention group
Group type: COMPARATOR
Intervention: Less invasive treatments
Number of subjects: 14029
Study 35222693 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxibustion
Number of subjects: 104
Study 35222693 — intervention group
Group type: COMPARATOR
Intervention: Sham moxibustion
Number of subjects: 104
Study 32471404 — intervention group
Group type: EXPERIMENTAL
Intervention: Theory-based back care training program (T-Bak) consisting of six sessions on proper lifting, carrying techniques, posture, and backpack wearing
Number of subjects: 104
Study 32471404 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 104
Study 35471469 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg/day tolvaptan (TLV) plus original FUR dose for 7 days
Number of subjects: 33
Study 35471469 — intervention group
Group type: COMPARATOR
Intervention: 120–200 mg/day furosemide (FUR) for 7 days
Number of subjects: 33
Study 34187185 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide (1.8 mg once daily for 26 weeks)
Number of subjects: 102
Study 34187185 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once daily for 26 weeks)
Number of subjects: 102
Study 34187185 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 102
Study 34187185 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study 34187185 — intervention group
Group type: EXPERIMENTAL
Intervention: Explorative analysis
Number of subjects: 102
Study 34148643 — intervention group
Group type: EXPERIMENTAL
Intervention: Multimodal protocol combining a motivational interview, subcutaneous injection of NicoSan®, and hyperhydration.
Number of subjects: 554
Study 33415868 — intervention group
Group type: EXPERIMENTAL
Intervention: Warm acupuncture at Yifeng (TE 17) combined with conventional acupuncture
Number of subjects: 68
Study 33415868 — intervention group
Group type: COMPARATOR
Intervention: TDP plus conventional acupuncture
Number of subjects: 68
Study 35590388 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% topical diclofenac gel
Number of subjects: 264
Study 35590388 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 264
Study 34424331 — intervention group
Group type: EXPERIMENTAL
Intervention: CHW intervention
Number of subjects: 287
Study 34424331 — intervention group
Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 287
Study 32528409 — intervention group
Group type: EXPERIMENTAL
Intervention: Geriatric multimodal intervention
Number of subjects: 0
Study 32528409 — intervention group
Group type: EXPERIMENTAL
Intervention: CAPACITY technological ecosystem support
Number of subjects: 0
Study 33546255 — intervention group
Group type: EXPERIMENTAL
Intervention: multi-domain CCT + PE
Number of subjects: 347
Study 33546255 — intervention group
Group type: EXPERIMENTAL
Intervention: two-domain CCT + PE
Number of subjects: 347
Study 33546255 — intervention group
Group type: COMPARATOR
Intervention: video watching + PE (control)
Number of subjects: 347
Study 32901984 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-based support program
Number of subjects: 258
Study 32901984 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care + Internet-based support program
Number of subjects: 258
Study 32901984 — intervention group
Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 258
Study 34324394 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-automated software for osteoporosis risk assessment
Number of subjects: 567
Study 34324394 — intervention group
Group type: EXPERIMENTAL
Intervention: Fully automated tool for osteoporosis risk assessment
Number of subjects: 567
Study 34324394 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-automated software and fully automated tool
Number of subjects: 567
Study 34480575 — intervention group
Group type: EXPERIMENTAL
Intervention: SCB-2019 vaccine (3, 9, or 30 µg doses)
Number of subjects: 0
Study 34480575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36097167 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT plus abiraterone
Number of subjects: 1125
Study 34518157 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-week supervised exercise intervention
Number of subjects: 20
Study 35742477 — intervention group
Group type: EXPERIMENTAL
Intervention: m‐Health app (10,000 steps/day)
Number of subjects: 130
Study 35742477 — intervention group
Group type: COMPARATOR
Intervention: Control group (information related to daily recommended PA levels)
Number of subjects: 130
Study 33706084 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 80 mg
Number of subjects: 9980
Study 33706084 — intervention group
Group type: COMPARATOR
Intervention: Atorvastatin 10 mg
Number of subjects: 9980
Study 32641376 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 12
Study 32641376 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 36478528 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 12 μg
Number of subjects: 24
Study 36478528 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 18 μg
Number of subjects: 24
Study 36478528 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta 24 μg
Number of subjects: 24
Study 36478528 — intervention group
Group type: EXPERIMENTAL
Intervention: Follitropin delta (all doses)
Number of subjects: 24
Study 33799044 — intervention group
Group type: EXPERIMENTAL
Intervention: CORT (20mg oral cortisol)
Number of subjects: 75
Study 33799044 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 33025815 — intervention group
Group type: EXPERIMENTAL
Intervention: Radial access
Number of subjects: 44804
Study 33025815 — intervention group
Group type: COMPARATOR
Intervention: Femoral access
Number of subjects: 44804
Study 35477898 — intervention group
Group type: EXPERIMENTAL
Intervention: 30-minute Stroop task to induce mental fatigue (MF)
Number of subjects: 17
Study 35477898 — intervention group
Group type: COMPARATOR
Intervention: Watching a documentary for 30 minutes (control)
Number of subjects: 17
Study 34176392 — intervention group
Group type: EXPERIMENTAL
Intervention: Balovaptan (10 mg or 50 mg)
Number of subjects: 93
Study 34176392 — intervention group
Group type: COMPARATOR
Intervention: Balovaptan (0.5–76 mg single dose; 12–52 mg/day multiple doses for 14 days)
Number of subjects: 93
Study 34176392 — intervention group
Group type: COMPARATOR
Intervention: Balovaptan (32 mg single dose)
Number of subjects: 93
Study 34176392 — intervention group
Group type: EXPERIMENTAL
Intervention: Balovaptan (≤76 mg single dose; ≤52 mg/day multiple doses)
Number of subjects: 93
Study 32057905 — intervention group
Group type: EXPERIMENTAL
Intervention: Compendial Apparatus IV
Number of subjects: 0
Study 32057905 — intervention group
Group type: EXPERIMENTAL
Intervention: tiny-TIM system
Number of subjects: 0
Study 32057905 — intervention group
Group type: COMPARATOR
Intervention: Compendial Apparatus I and II
Number of subjects: 0
Study 35397750 — intervention group
Group type: EXPERIMENTAL
Intervention: SG + LC
Number of subjects: 222
Study 35397750 — intervention group
Group type: COMPARATOR
Intervention: SG only
Number of subjects: 222
Study 35397750 — intervention group
Group type: COMPARATOR
Intervention: Delayed LC
Number of subjects: 222
Study 34639631 — intervention group
Group type: EXPERIMENTAL
Intervention: Wireless vital parameter continuous monitoring (WVPCM)
Number of subjects: 110
Study 34639631 — intervention group
Group type: COMPARATOR
Intervention: Regular monitoring (Control group)
Number of subjects: 110
Study 34637892 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-implant mandibular overdenture (SIMO)
Number of subjects: 65
Study 34637892 — intervention group
Group type: COMPARATOR
Intervention: Conventional complete denture (CCD)
Number of subjects: 65
Study 33242083 — intervention group
Group type: EXPERIMENTAL
Intervention: 3-week antibiotic therapy
Number of subjects: 93
Study 33242083 — intervention group
Group type: COMPARATOR
Intervention: 6-week antibiotic therapy
Number of subjects: 93
Study 32611864 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc oxide-propolis mixture
Number of subjects: 40
Study 32611864 — intervention group
Group type: COMPARATOR
Intervention: Zinc oxide eugenol (ZOE)
Number of subjects: 40
Study 32729721 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular (equal-interval) graph
Number of subjects: 72
Study 32729721 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Celeration Chart (SCC; semi-log)
Number of subjects: 72
Study 32729721 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Behavior Graph (SBG; semi-log)
Number of subjects: 72
Study 32729721 — intervention group
Group type: EXPERIMENTAL
Intervention: User acceptability
Number of subjects: 72
Study 34539805 — intervention group
Group type: EXPERIMENTAL
Intervention: ColonVita
Number of subjects: 100
Study 34539805 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 34786853 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led home-based telephone support and home visits (intervention group)
Number of subjects: 172
Study 34786853 — intervention group
Group type: COMPARATOR
Intervention: Home visits alone (control group)
Number of subjects: 172
Study 32160779 — intervention group
Group type: EXPERIMENTAL
Intervention: BioMatrix biolimus-eluting stent (BES)
Number of subjects: 1911
Study 32160779 — intervention group
Group type: COMPARATOR
Intervention: Xience everolimus-eluting stent (EES)
Number of subjects: 1911
Study 32160779 — intervention group
Group type: COMPARATOR
Intervention: Resolute zotarolimus-eluting stent (ZES)
Number of subjects: 1911
Study 35164605 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise program
Number of subjects: 180
Study 35164605 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program
Number of subjects: 180
Study 35164605 — intervention group
Group type: COMPARATOR
Intervention: Attention-control group
Number of subjects: 180
Study 32356108 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D laparoscopic distal gastrectomy
Number of subjects: 79
Study 32356108 — intervention group
Group type: COMPARATOR
Intervention: 2D laparoscopic distal gastrectomy
Number of subjects: 79
Study 32422097 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation
Number of subjects: 0